Funded by
the European Union

Author name: admin

New EuCARE Study Presented at the Nordic HIV & Virology Conference 2025

We are proud to share that our study, “Risk of Long COVID Symptoms and Conditions After SARS-CoV-2 Compared to Other Respiratory Viral Infections: A Systematic Review and Meta-Analysis”, was presented as a poster at the Nordic HIV & Virology Conference 2025. The research highlights:✅ Higher risk of long-term symptoms such as pulmonary embolism, fatigue, abnormal […]

New EuCARE Study Presented at the Nordic HIV & Virology Conference 2025 Read More »

Why do some healthcare workers hesitate to vaccinate?

A EuCARE survey with 2,079 HCWs across 🇵🇹 🇧🇷 🇩🇪 🇵🇱 🇱🇹 — led by Prof. Francis Drobniewski (Imperial College London) — revealed: What helped? Easy workplace access, clear scientific info, and seeing peers get vaccinated. 👉 One lesson: vaccine promotion must be tailored — not one-size-fits-all. Read the full manuscript here!

Why do some healthcare workers hesitate to vaccinate? Read More »

🇧🇷 On August 25, EuCARE partners gathered at UFMG, for a dedicated PAIS meeting.

On August 25, EuCARE partners gathered prestigious seat of the Faculty of Medicine of UFMG, Belo Horizonte, for a dedicated Post Acute Infection Syndrome (PAIS) meeting. Julia Caporali (UFMG), Dario Corsini (EuResist), Francesca Incardona (EuResist), Jorge Pinto (UFMG) and Flavia Faleiro (UFMG) talked about the ongoing studies and perspectives.🔹 PAIS is attracting interest after the

🇧🇷 On August 25, EuCARE partners gathered at UFMG, for a dedicated PAIS meeting. Read More »

Nordic HIV & Virology Conference 2025

Nordic HIV & Virology Conference 2025 | 24–26 September | Stockholm, Sweden 🇸🇪 The Nordic HIV & Virology Conference is back with another excellent scientific programme, bringing together leading experts to share the latest advancements in HIV and virology research. 💡 Key info:🔹 Deadline for abstract submission: 25 August 2025🔹 PhD students with accepted abstracts:

Nordic HIV & Virology Conference 2025 Read More »

New EuCARE publication on Long COVID and immune response

What drives persistent symptoms after COVID-19? A newly published study from the EuCARE team explores how SARS-CoV-2 RNAemia (the presence of viral RNA in the blood) and immune dysregulation may explain the early persistence of symptoms in unvaccinated, hospitalised patients. 📌 Key findings:– Patients with persistent symptoms had a weaker immune response and lower levels of

New EuCARE publication on Long COVID and immune response Read More »

📄 “Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-Analysis”

This systematic review and meta-analysis examined how pandemic-related healthcare disruptions led to delays in melanoma diagnoses, resulting in a shift toward more advanced and severe cases. Key findings: ✅ A higher prevalence of poor prognostic factors (thickness, ulceration, mitosis). ✅ A significant increase in advanced-stage melanoma (Stage III & IV). ✅ Highlights the urgent need for updated pandemic preparedness plans to safeguard oncological care. Read

📄 “Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-Analysis” Read More »

Scenes from Barcelona

This week, the EuCARE team participated in the 23rd European Meeting on HIV & Hepatitis, held in the vibrant city of Barcelona 🇪🇸 We proudly contributed with:🎤 1 oral presentation📌 2 poster presentations This was a fantastic opportunity to share our work, especially on the SCHOOL studies and clinical cohorts, while engaging in meaningful exchanges

Scenes from Barcelona Read More »